Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS–Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China-Reference-Cited by-同舟云学术

Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS–Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China

Published:2014-09-26 Issue:11 Volume:34 Page:783-793
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Hou Xiaohua,Chen Shengliang,Zhang Yali,Sha Weihong,Yu Xiaofeng,Elsawah Hesham,Afifi Afifi Fahmy,El-Khayat Hisham Raafat,Nouh Alaa,Hassan Mohamed Fathalla,Fatah Ayman Abdel,Rucker Joerg Isabel,Sánchez Núñez Juan Manuel,Osthoff Rueda Rodolfo,Jurkowska Grazyna,Walczak Michal,Malecka-Panas Ewa,Linke Krzysztof,Hartleb Marek,Janssen-van Solingen Gwendolyn

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s40261-014-0233-y/fulltext.html

Reference15 articles.

1. Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS-QOL: a disease–specific, quality–of–life questionnaire. Am J Gastroenterol. 2000;95(4):999–1007.

2. Drossman DA, Morris CB, Schneck S, et al. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol. 2009;43(6):541–50.

3. Kawanawa M, Drossman DA, Shonozaki M, et al. Translation and validation of a Japanese version of the irritable bowel syndrome quality of life measure (IBS-QOL–J). BioPsychoSoc Med. 2007;1:6.

4. Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654–60.

5. Mönnikes H, Hecker H, Heymann–Mönnikes I. Predictive factors for therapeutic success in irritable bowel syndrome (IBS) in primary care (PrC) 2001. Z Gastroenterol. p. 39.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for irritable bowel syndrome: A review;Terapevticheskii arkhiv;2024-03-30

2. Dietary Interventions and Brain–Gut Disorders;The Gut-Brain Axis;2024

3. Irritable bowel syndrome: modern ideas about pathology and the possibility of its correction;Meditsinskiy sovet = Medical Council;2023-11-04

4. Effects of irritable bowel syndrome on the health-related quality of life among the Saudi population;Saudi Journal of Gastroenterology;2023-06-22

5. The place of antispasmodic drugs in modern therapy of irritable bowel syndrome;Meditsinskiy sovet = Medical Council;2023-05-25